Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | BCHE | P06276 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
| ▸ | KIF11 | P52732 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11435958 | 0.78 | GABRA1 (0.48) | ALDH1A1TSHRTDP1CA2BCHE | |
| SCHEMBL25456413 | 0.73 | ALDH1A1 (0.38) | ALDH1A1TSHRTDP1CA2BCHE | |
| SCHEMBL9838551 | 0.72 | ALDH1A1 (0.48) | ALDH1A1TSHRTDP1CA2BCHE | |
| SCHEMBL5435016 | 0.72 | ALDH1A1 (0.48) | ALDH1A1TSHRTDP1CA2BCHE | |
| SCHEMBL9720280 | 0.72 | ALDH1A1 (0.41) | ALDH1A1TSHRTDP1CA2ATM | |
| SCHEMBL10398717 | 0.72 | ALDH1A1 (0.36) | ALDH1A1TSHRTDP1CA2BCHE | |
| SCHEMBL156581 | 0.70 | TSHR (0.50) | ALDH1A1TSHRTDP1CA2 | |
| SCHEMBL29678719 | 0.70 | TSHR (0.50) | ALDH1A1TSHRTDP1CA2 | |
| SCHEMBL1315822 | 0.70 | ALDH1A1 (0.35) | ALDH1A1TSHRTDP1CA2 | |
| SCHEMBL13032299 | 0.70 | ALDH1A1 (0.46) | ALDH1A1TSHRTDP1CA2BCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230165134-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-05-25 | — | — | US | disclosed |
| US-11476430-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2022-10-18 | — | — | US | disclosed |
| US-20200119289-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2020-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230165134-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, TPO | ALDH1A1 721/4885TSHR 1568/4885TDP1 2140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.